메뉴 건너뛰기




Volumn 14, Issue 1, 1988, Pages 13-34

Clinical Pharmacokinetics of Ketoconazole

Author keywords

[No Author keywords available]

Indexed keywords

KETOCONAZOLE;

EID: 0023737640     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/00003088-198814010-00002     Document Type: Review
Times cited : (187)

References (138)
  • 2
    • 0019169555 scopus 로고
    • Determination of the antifungal agent, ketoconazole, in human plasma by high performance liquid chromatography
    • (1980) Journal of Chromatography , vol.221 , pp. 337-344
    • Alton, K.B.1
  • 62
    • 85025884285 scopus 로고    scopus 로고
    • Hendricks R, Michiels M, Heykants J. Radioimmunoassay for ketoconazole (R4100) and terconazole (R42470). Janssen Preclinical Research Report No. R 41400/50, 1983
  • 64
    • 84951678860 scopus 로고    scopus 로고
    • Heykants JJP, Woestenborghs RJH, Schejgrond H, Dony J, Lamiere N. Plasma levels and urinary excretion of ketoconazole following oral administration to patients with severe renal insufficiency. Janssen Clinical Research Report No. R41400/56, 1980
  • 66
    • 84951678861 scopus 로고    scopus 로고
    • Hoeprich PD, Merry JM, Gunther R, Franti CE. Entry of four antifungal antimicrobics into the ovine lung. Annual Meeting of the American Society for Microbiology, Las Vegas, Nevada, USA, March 3–7, 1985. Abstract no. F26, 1985
  • 92
    • 84951678862 scopus 로고    scopus 로고
    • Meuldermans W, Hurkmans R, Swijsen E, Heykants J. The binding of R 41 400 to human plasma proteins and blood cells, and to subcellular fractions of rat liver, lung, kidney and small intestine. Preclinical Research Report, Janssen Pharmaceutica, no. R 41400/24, 1978a
  • 93
    • 84951678863 scopus 로고    scopus 로고
    • Meuldermans W, Lauwers W, Swijsen E, Hendrickx J, Heykants J. The biliary excretion of R 41 400 and its metabolites in the rat after oral administration of the tritium labelled drug. Preclinical Research Report, Janssen Pharmaceutica, No. R 41400/16, 1978b
  • 94
    • 84951678864 scopus 로고    scopus 로고
    • Meunier-Carpentier F, Heymans C, Snoeck R. Interaction of rifampicin with ketoconazole and Bay n7133 in normal volunteers. Presented at the 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Las Vegas, October 24–26, 1983
  • 95
    • 84951678865 scopus 로고    scopus 로고
    • Michiels M, Lorreyne W, Woestenborghs R, Heykants J. Absorption of ketoconazole after repeated vaginal application to near-term female Beagle dogs. Preclinical Research Report, Janssen Pharmaceutica, No. 41400/48, 1983a
  • 96
    • 84951678866 scopus 로고    scopus 로고
    • Michiels M, Prinsen P, Heykants J, Van Cutsem J. Absorption and plasma levels of ketoconazole after oral and vaginal administration to the Wistar rat. Preclinical Research Report, Janssen Pharmaceutica, No. R 41400/46, 1983b
  • 97
    • 84951678867 scopus 로고    scopus 로고
    • Michiels M, Van Peer A, Van Ravestijn C, Marsboom R, Lorreyne W, et al. Absorption of ketoconazole in the dog after repeated vaginal application and after application on the intact and abraded skin. Preclinical Research Report, Janssen Pharmaceutica, No. R 41400/41, 1982
  • 99
    • 0022354460 scopus 로고
    • Treatment of blastomycosis and histoplasmosis with ketoconazole: results of a prospective randomized clinical trial
    • Mycoses Study Group
    • (1985) Annals of Internal Medicine , vol.103 , pp. 861-872
  • 108
    • 84951678868 scopus 로고    scopus 로고
    • Rawlins M. Systemic absorption of ketoconazole 2% cream and ketoconazole 400mg vaginal pessaries. Clinical Research Report, Janssen Pharmaceutica, No. N31403, 1982
  • 130
    • 84951678871 scopus 로고    scopus 로고
    • Van Peer A, Woestenborghs R, Heykants J, Mesens J, Caers I, et al. Oral availability in man of 400mg of ketoconazole, given as 200mg capsules containing ketoconazole on a citric acid carrier, and as two suspension formulations. Janssen Clinical Research Report, no. R 41 400/120, 1984
  • 131
    • 84951678872 scopus 로고    scopus 로고
    • Van Peer A, Woestenborghs R, Heykants J, Mesens J, Cauwenbergh G. Further studies on the oral bioavailability of ketoconazole in man: comparison of 200mg in tablets, and in capsules with ketoconazole on a citric acid carrier: influence of pretreatment with an antacid and Cimetidine. Janssen Clinical Research Report, no. R 41 400/115, 1983
  • 132
    • 0021716851 scopus 로고
    • Ketoconazole, mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use
    • (1984) Pharmacotherapy , vol.4 , pp. 343-373
    • Van Tyle, J.H.1
  • 135
    • 84951678873 scopus 로고    scopus 로고
    • Woestenborghs R, Embrechts L, Heykants J. A HPLC method for the specific determination of ketoconazole in plasma. Preclinical Research Report, Janssen Pharmaceutica, R41400/34, 1980
  • 136
    • 85025885529 scopus 로고    scopus 로고
    • Woestenborghs R, Heykants J. Bioavailability of ketoconazole in saliva. Clinical Research Report, Janssen Pharmaceutica, R 41400/71, 1982
  • 137
    • 84951678875 scopus 로고    scopus 로고
    • Woestenborghs R, Lorreyne W, Heykants J. A high-performance liquid chromatographic method for the determination of ketoconazole in human plasma: validation and application to the bioavailability and dose proportionality study in man. Preclinical Research Report, Janssen Pharmaceutica R41400/42, 1982
  • 138
    • 85025913327 scopus 로고    scopus 로고
    • Woestenborghs R, Michielsen L, Michiels M, Heykants J. Gas chromatographic determination of R41400 in plasma, urine, faeces and tissues. Preclinical Research Report, Janssen Pharmaceutica, R41400/18, 1978


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.